Retia Medical Systems, Inc.


Retia Medical is dedicated to advancing hemodynamic monitoring technology to improve patient outcomes. They develop accurate, easy-to-use, and affordable cardiovascular monitors, notably the Argos Cardiac Output Monitor, which utilizes proprietary algorithms for superior performance. Their mission is to provide clinicians with reliable data to support confident, data-driven patient care decisions across various clinical settings, including ICU, OR, and beyond.

Industries

biotechnology
hardware
software

Nr. of Employees

small (1-50)


Products

Cardiac output monitoring system (non‑invasive/minimally‑invasive)

Bedside hemodynamic monitor that estimates cardiac output and derived parameters from peripheral blood pressure waveforms using a multi‑beat signal analysis algorithm; designed for use in operating rooms and intensive care units for adult patients.


Services

Webinars and on‑demand video training focused on hemodynamic monitoring principles, perioperative goal‑directed fluid therapy, and device operation for clinicians.

Scheduling of product demonstrations and clinical sales support to evaluate device performance and facilitate procurement decisions.

Collaboration with specialty medical distributors and strategic partners to expand market coverage and provide local sales and clinical support.

Expertise Areas

  • Hemodynamic monitoring
  • Cardiovascular signal processing
  • Algorithm development for physiological signals
  • Clinical validation of monitoring devices
  • Show More (3)

Key Technologies

  • Multi‑beat signal analysis algorithm
  • Cardiac output monitoring (non‑invasive/minimally‑invasive)
  • Cardiovascular signal processing
  • EMR connectivity and vendor‑agnostic interfaces
  • Show More (3)

News & Updates

Retia Medical installed its Argos Cardiac Output monitor at Johns Hopkins, providing access to advanced hemodynamic monitoring technology to optimize cardiac function during critical care.

Retia Medical announced the issuance of two patents, US 10,251,566 and US 10,349,838, expanding coverage in advanced algorithms for accurate hemodynamic monitoring using less invasive sensors.

Retia Medical announced the issuance of two patents, US 8,282,569 and US 8,273,031, expanding coverage in cardiovascular signal processing for accurate monitoring of critically ill patients using less invasive sensors.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.